Australian law firm files class action against Johnson & Johnson over ‘ineffective’ cold and flu medication
By Mary Lloyd, ABC News
A box of Sudafed PE sinus pressure and pain medicine containing phenylephrine is displayed for sale.
Photo: PATRICK T. FALLON / AFP
An Australian law firm has filed a class action against global pharmaceutical giant Johnson & Johnson, accusing it of selling medicines known to be ineffective.
Lawyers at JGA Saddler allege the company falsely stated medications such as Codral Day and Night, Sudafed PE and Benadryl PE relieve congestion.
The action relates to tablets containing phenylephrine, a substance which the US Food and Drug Administration (FDA) last year declared was not an effective nasal decongestant when taken in tablet form.
Johnson & Johnson's advertising for Codral Day and Night states, "Phenylephrine helps to relieve blocked and runny noses"...